Docon Technologies, one of the promoters of Thyrocare Technologies, has sold a 10 per cent stake in the diagnostics firm for ₹667 crore through an open market transaction.
According to bulk deal data from the National Stock Exchange (NSE), the company offloaded over 53.32 lakh shares, representing 10.06 per cent equity in Thyrocare, at an average price of ₹1,252.03 per share, amounting to a total value of around ₹667.69 crore.